Oximesa Nippon Gases

Name

Oximesa Nippon Gases

Legal name

OXIMESA, S.L.U.

Website

https://oximesa.es

Company type

Private

Founded year

1966

Operating status

Operating

Headcount range

251–500 employees

Short description

Oximesa is a wholly-owned subsidiary of Nippon Gases that provides home respiratory therapy services across Spain, including oxygen therapy, mechanical ventilation, sleep apnea treatment, aerosoltherapy, chronic patient telemonitoring, and diagnostic studies, serving patients prescribed through the Spanish National Health System via a network of 27+ local delegations and CentrOx patient care centers.

Ownership category

akta.pro rank

Product category

Home Respiratory Healthcare Services

NAICS

Home Health Care Services (62161)

SIC

Services-Home Health Care Services (8082)

akta.pro primary industry

Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM)

akta.pro secondary industries

Respiratory & Sleep RPM (COPD, asthma, sleep apnea) (HLALAFAB), Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC) (HLAHAGAD), Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate) (HLAHAGAI), Pulmonology & Sleep Medicine Telemedicine Platforms (HLALAGAF)

Keywords

• Home respiratory therapy
• Medical gas supply
• Chronic patient care
• Sleep apnea treatment
• Oxygen therapy services

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices27 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Respiratory therapy services: Home respiratory therapy services provided to patients including oxygen therapy, mechanical ventilation, aerosoltherapy, and sleep disorder treatments. Services are prescribed by medical specialists and delivered at patient homes with ongoing monitoring and support.
2. Medical equipment provision: Provision and maintenance of respiratory therapy equipment including monitors, nebulizers, CPAP devices, oxygen concentrators, and related medical devices for home use.
3. Patient Support Programs (PSP): Patient support programs for pharmaceutical companies providing training, technical support, and troubleshooting services for patients using medical devices with their medications.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

Oximesa is a Spanish home healthcare services company that delivers prescribed home respiratory therapies to patients, including oxygen therapy, aerosoltherapy, non-invasive mechanical ventilation, sleep apnea therapies (CPAP/AutoCPAP), and continuous vital sign monitoring. The company also operates the Nippon Sanso Healthcare hospital division for medical gas supply and provides patient support programs for pharmaceutical companies, supported by a nationwide network of local delegations and CentrOx patient care centers.

Product overview

Oximesa is a home healthcare services company specializing in respiratory therapies, offering a comprehensive portfolio of products and services organized around five core areas. The primary offering is respiratory therapies encompassing six distinct services: constant monitoring (apnea monitors and pulse oximetry), support therapies (secretion mobilization and aspiration equipment), aerosol therapy (nebulizers), non-invasive mechanical ventilation, sleep therapies (CPAP/AutoCPAP), and oxygen therapy. Supporting the core therapies are home diagnostic studies (polysomnography, polygraphy, pulse oximetry, CPAP titration, walking tests), chronic patient telemonitorization for remote health monitoring, and the hospital division Nippon Sanso Healthcare for medical gas provision. The company operates a network of CentrOx care centers across Spain and provides patient support programs, a professional access portal, and 24/7 contact center services.

Differentiator

Problem solved

Functional benefit

Brands

• CentrOx: CentrOx centers providing patient care and attention services
• Nippon Sanso Healthcare
• Oximesa Solidaria
• Contact Center Sanitario

Products and services

• Monitorización de constantes (Vital Sign Monitoring)

Quantifiable outcome

• 60% reduction in hospitalizations for chronic patients under telemonitoring
• +4 more outcomes

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Three partnerships are on record, tiered minor and core.

• CarbonneutralworldminorOthersSubsidiary company of Oximesa/Nippon Gases focused on carbon neutral solutions and environmental sustainability initiatives.
• Nippon Sanso HealthcarecoreOthersHealthcare division of Nippon Sanso focused on hospital medical gas supply, R&D of new hospital technologies and respiratory care solutions. Provides medical gases, pharmaceutical manufacturing, and distribution infrastructure.
• Spanish National Health SystemcoreStrategic or Co-development PartnerHealthcare system integration providing home respiratory therapies prescribed through public healthcare channels, coordinating with regional health services and hospitals across Spain.

Scale indicators14 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Fisher & Paykel Healthcare: Manufacturer of respiratory humidification, CPAP, and home oxygen therapy products. Comparable on the device/technology side of Oximesa's respiratory therapy offerings, particularly in nasal high-flow and home oxygen.
• Philips Respironics: Global incumbent in sleep and respiratory devices (CPAP, BiPAP, ventilators) and remote monitoring. Overlaps with Oximesa's sleep therapy and ventilation offerings, though Philips operates primarily as a manufacturer rather than a homecare service operator.
• Air Products Healthcare: Industrial gas major with medical gas and homecare operations in select European markets. Overlaps with Oximesa on medical oxygen supply and respiratory therapies, though with a smaller Spain-specific homecare footprint.
• ResMed: Global leader in CPAP and connected sleep apnea devices, with growing software/RPM capabilities. Comparable in the sleep apnea therapy vertical where Oximesa offers CPAP/AutoCPAP, though ResMed is primarily a device manufacturer rather than a service provider.

Direct peers

• VitalAire (Air Liquide Healthcare): Air Liquide's home healthcare division operating in Spain, providing home oxygen therapy, CPAP, ventilation, and chronic respiratory care — directly comparable to Oximesa on service portfolio, payer mix, and Spanish market presence.
• Linde Healthcare: Linde's medical gases and home respiratory care business in Spain, offering oxygen therapy, sleep apnea treatment, and hospital medical gas services — a direct competitor with comparable full-portfolio respiratory services.
• Messer Iberica: Medical gases and home respiratory care provider in Spain, part of the Messer Group, offering oxygen therapy, ventilation, and related home services — competes directly with Oximesa in the Spanish homecare market.

Emerging players

• Doccla: European virtual ward and remote patient monitoring provider focused on chronic conditions including respiratory. Comparable to Oximesa's telemonitoring arm, though operating as a technology platform rather than a full-service respiratory provider.
• Tunstall Healthcare: European provider of remote patient monitoring and telehealth platforms, including chronic condition management. Comparable to Oximesa's telemonitoring and chronic patient care services, with similar patient populations but a software/technology-led model.

Others

• Solventum (formerly 3M Health Care): Healthcare solutions provider active in respiratory and patient monitoring adjacencies. Indirectly comparable as an adjacent technology and supplies ecosystem participant to Oximesa's respiratory therapy infrastructure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/OximesaNG
• Facebookfacebook.com/hopkintonhomecare
• LinkedInlinkedin.com/company/oximesang

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oximesa Nippon Gases